Scholarlink

<p>This review explores the bidirectional relationship between lipids and extracellular vesicles (EVs) throughout the EV lifecycle. Lipid metabolism and lipid signaling influence EV biogenesis, cargo sorting, release, and targeting. EVs are key mediators of intercellular and interorgan communication. The cargoes carried by EVs can affect lipid metabolism and signaling pathways in target organs, thereby regulating diverse physiological and pathological processes. Recent studies indicate that EVs play critical roles in the pathological progression of various lipid metabolism-related diseases, such as obesity, type 2 diabetes (T2DM), non-alcoholic fatty liver disease (NAFLD), atherosclerosis, and cancer. Importantly, disease states induce characteristic alterations in the lipid composition of circulating EVs. These disease-specific EVs show great promise as non-invasive diagnostic biomarkers. As detailed in this review, understanding the intricate interplay between lipid metabolism, lipid signaling, and EV is essential for elucidating fundamental EV biology and developing novel EV-based diagnostic and therapeutic strategies.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lipid metabolism and lipid signaling in extracellular vesicles ontogeny: from biogenesis to functional execution

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月14日

查看全文
  • Jiaxin Zhang,
  • Jiali Li,
  • Yuzhou Zheng,
  • Chenyang Zhu,
  • Zhijing Wu,
  • Tangrong Wang,
  • Yu Li,
  • Jian Zhu,
  • Sen Wei,
  • Hui Qian,
  • Zixuan Sun

摘要

This review explores the bidirectional relationship between lipids and extracellular vesicles (EVs) throughout the EV lifecycle. Lipid metabolism and lipid signaling influence EV biogenesis, cargo sorting, release, and targeting. EVs are key mediators of intercellular and interorgan communication. The cargoes carried by EVs can affect lipid metabolism and signaling pathways in target organs, thereby regulating diverse physiological and pathological processes. Recent studies indicate that EVs play critical roles in the pathological progression of various lipid metabolism-related diseases, such as obesity, type 2 diabetes (T2DM), non-alcoholic fatty liver disease (NAFLD), atherosclerosis, and cancer. Importantly, disease states induce characteristic alterations in the lipid composition of circulating EVs. These disease-specific EVs show great promise as non-invasive diagnostic biomarkers. As detailed in this review, understanding the intricate interplay between lipid metabolism, lipid signaling, and EV is essential for elucidating fundamental EV biology and developing novel EV-based diagnostic and therapeutic strategies.

Graphical abstract